ImmunityBio Inc. (IBRX)

NASDAQ: IBRX · Real-Time Price · USD

2.49

-0.02 (-0.80%)

At close: May 01, 2025, 3:59 PM

2.46

-1.20%

After-hours: May 01, 2025, 07:55 PM EDT

ImmunityBio Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-413.64M	-583.2M	-417.32M	-349.85M	-224.19M	-160.16M	-96.23M	-96.42M	-120.81M
Depreciation & Amortization	17.55M	18.51M	18.26M	14.24M	12.74M	14.04M	9.55M	5.57M	3.61M
Stock-Based Compensation	34.43M	49.16M	40.18M	57.18M	2.19M	3.42M	2.04M	37M	73.85M
Other Working Capital	n/a	10.45M	-16M	-15.39M	13.79M	-16.82M	546K	3.08M	2.95M
Other Non-Cash Items	-29.58M	144.79M	29.38M	23.13M	24.11M	6.23M	44.55M	50.33M	81.67M
Deferred Income Tax	n/a	n/a	-4K	-8K	-2.94M	-8K	-498K	-497K	-575K
Change in Working Capital	n/a	3.98M	-8M	-19.11M	16.36M	-15.64M	-554K	3.23M	3.84M
Operating Cash Flow	-391.24M	-366.76M	-337.51M	-274.42M	-171.72M	-152.11M	-63.38M	-48.78M	-38.59M
Capital Expenditures	-6.89M	-30.58M	-99.39M	-33.56M	-1.67M	-4.29M	-13.1M	-34.81M	-6.56M
Cash Acquisitions	-1M	n/a	-1M	20.5M	8K	200K	412K	-32K	-137K
Purchase of Investments	-140.22M	-10.36M	-34.31M	-141.75M	-91.77M	-87.19M	-95.49M	-119.86M	-273M
Sales Maturities Of Investments	136.61M	10.47M	162M	69.93M	73.62M	112.33M	165.28M	254.22M	165.89M
Other Investing Acitivies	-747K	n/a	105.46M	-51.32M	-8K	-2.5M	35.03M	32K	137K
Investing Cash Flow	-12.25M	-30.47M	27.3M	-84.89M	-19.81M	18.55M	57.1M	99.55M	-113.67M
Debt Repayment	-64K	258.62M	174.07M	338.5M	63.7M	47.67M	-477K	-19.93M	-32K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	-2.5M	-228K	-15.23M	-15.85M
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	170.34M	189.62M	-881K	2.41M	673K	39.11M	-123K	-1.04M	-1.11M
Financial Cash Flow	281.63M	558.34M	233.61M	505.44M	150.68M	114.28M	-771K	-34.98M	-15.56M
Net Cash Flow	-121.88M	160.82M	-76.31M	146.19M	-40.89M	-19.3M	-7.05M	15.79M	-167.82M
Free Cash Flow	-398.12M	-397.34M	-436.9M	-307.98M	-173.39M	-156.4M	-76.48M	-83.59M	-45.15M